Delivery Order SPE2DB22D2206-SPE2DB24FEQ70
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,977.00 contract is for the procurement of "VISCOAT SYRINGE 0.75ML" medical supplies, with a firm fixed price and an ultimate completion date of July 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $11,591.33 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VISCOAT SYRINGE 0.75ML medical products, with a performance period through January 23, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $7,515.30 firm fixed price contract is for the supply of VISCOAT SYRINGE 0.75ML medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,131.62 firm fixed price contract is for the delivery of VISCOAT SYRINGE 0.5ML medical supplies, with a completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of a medical product, specifically "VISCOAT SYRINGE 0.75ML", with a ceiling value of $1,242.68 and a completion date of September 26, 2024. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business type. Amerisourcebergen has been awarded numerous...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for medical supplies. The contract is for "VISCOAT SYRINGE 0.75ML" with a firm fixed price of $12,653.04 and a performance period through January 30, 2025. The award has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide VISCOAT SYRINGE 0.75ML medical supplies. The contract, valued at $3,006.12, is a firm-fixed-price delivery order with a completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025, to deliver a range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,815.90, is for the delivery of 0.75ML VISCOAT syringes. The contract has a firm fixed price pricing type and an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VISCOAT SYRINGE 0.75ML medical products. The contract has a ceiling value of $13,778.05 and covers the period through September 4, 2024. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical...
- This federal contract award, valued at $4,666.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISCOAT SYRINGE 0.5ML, a medical supply item. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on January 8, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEQ70Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $7,914.25, is for the procurement of VISCOAT SYRINGE 0.75ML medical supplies. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there are no major subcontractors mentioned. The DLA, a defense agency, is the funding organization for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 12/14/23 |